Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
acetaminophen
acetaminophen
Brand names: Acephen, Feverall, Mapap, Mapap Meltaway, Mapap Rapid Tabs, Ofirmev, Tylenol, Tylenol Childrens
| Form | Strength |
|---|---|
| LIQUID, ORAL | 160 mg/5 mL |
| SOLUTION, INTRAVENOUS | 10 mg/mL |
| SUPPOSITORY, RECTAL | 80 mg; 120 mg; 325 mg; 650 mg |
| SUSPENSION, ORAL | 160 mg/5 mL |
| TABLET, CHEWABLE, ORAL | 80 mg |
| TABLET, DISINTEGRATING, ORAL | 80 mg; 160 mg |
| TABLET, ORAL | 325 mg; 500 mg |
Last updated: Feb. 14, 2023
- Do Not Crush: CR Tablet
- Black Box Warning: Hepatotoxicity
- Restricted IV Acetaminophen (Ofirmev) is Formulary Restricted
acetaminophen
Intravenous (IV) orders will be automatically converted to enteral (PO) product for eligible patients. See Protocol 916.6007
IV Acetaminophen (Ofirmev) is a restricted formulary drug:
Surgical Patients:
- Preoperative use: only for use in patients with non-functioning GI tract or who cannot swallow medication with sip of water.
- Intraoperative use: not permitted
- Postoperative use: a surgical patient may receive IV acetaminophen if needed and NPO, for up to 24 hours. Use for greater than 24 hours may only be continued for patients with a non-functioning GI tract.
Non-surgical patients:
Usage is restricted to patients who cannot receive any oral medications and have one of the following clinical scenarios:
- Non-functioning GI tract
- Aspiration risk
- Dysphagia
- Intractable nausea and vomiting
For IV administration, see instructions for infusing from a glass bottle.